Sage Therapeutics, Inc.
SAGE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$400,666 | -$541,489 | -$532,784 | -$457,892 |
| Dep. & Amort. | -$5,450 | $1,393 | $1,122 | $4,182 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $54,504 | $73,367 | $61,602 | $104,629 |
| Change in WC | $84,762 | -$67,384 | $5,671 | -$18,506 |
| Other Non-Cash | -$344 | -$6,472 | $4,353 | -$10,595 |
| Operating Cash Flow | -$267,194 | -$540,585 | -$460,036 | -$378,182 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$553 | -$937 | -$372 |
| Net Acquisitions | $0 | $0 | -$326,370 | $1,002,076 |
| Inv. Purchases | -$450,957 | -$594,670 | -$881,037 | -$1,990,151 |
| Inv. Sales/Matur. | $717,635 | $1,038,136 | $1,207,407 | $988,075 |
| Other Inv. Act. | $0 | $0 | $326,370 | -$1,002,076 |
| Investing Cash Flow | $266,678 | $442,913 | $325,433 | -$1,002,448 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $8,164 | $6,930 | $3,113 | $14,719 |
| Stock Repurch. | $0 | -$903 | -$43 | -$1,385 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,499 | $6,027 | $3,070 | $13,334 |
| Financing Cash Flow | $10,663 | $6,027 | $3,070 | $13,334 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10,147 | -$91,645 | -$131,533 | -$1,367,296 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $72,324 | $163,969 | $295,502 | $1,662,798 |
| End Cash | $82,471 | $72,324 | $163,969 | $295,502 |
| Free Cash Flow | -$267,194 | -$541,138 | -$460,973 | -$378,554 |